Emend is used together with other medications to prevent nausea and vomiting that may be caused by chemotherapy. Emend is given ahead of time and will not treat nausea or vomiting that you already …

Use of EMEND with strong or moderate CYP3A4 inhibitors (e.g., ketoconazole, diltiazem) may increase plasma concentrations of aprepitant and result in an increased risk of adverse reactions...

Aprepitant, sold under the brand name Emend among others, is a medication used to prevent chemotherapy-induced nausea and vomiting and to prevent postoperative nausea and vomiting. [5]

Jan 24, 2024 · Emend (aprepitant) is a medication that's used to prevent nausea and vomiting caused by certain anti-cancer medications (chemotherapy). It's usually given an hour before your …

EMEND® is a substance P/neurokinin 1 (NK1) receptor antagonist. EMEND for oral suspension is indicated. EMEND has not been studied for treatment of established nausea and vomiting. Chronic …

Nov 4, 2024 · Oral administration of EMEND in combination with ondansetron and dexamethasone (EMEND regimen) has been shown to prevent acute and delayed nausea and vomiting associated …

Nov 26, 2024 · Find patient medical information for Aprepitant (Emend oral, Cinvanti, Aponvie) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

Jul 5, 2024 · EMEND® for oral suspension, in combination with other antiemetic agents, is indicated in patients 6 months of age and older for the prevention of: acute and delayed nausea and vomiting …

Jul 22, 2024 · Emend package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.

What are the most important things to know about oral aprepitant (Emend®) when receiving treatment? Remember to bring your aprepitant capsules with you to the infusion center to take before treatment!